_version_ 1784779436488392704
author Zaleska, J.
Kwaśnik, P.
Paziewska, M.
Purkot, J.
Szabelak, A.
Jurek, M.
Masny, N.
Dziatkiewicz, I.
Własiuk, P.
Skórka, K.
Stasiak, G.
Pronobis-Szczylik, B.
Piebiak, A.
Szymczyk, A.
Jarosz-Chudzik, K.
Bołkun, L.
Kozłowska, K.
Piszcz, J.
Subocz, E.
Hałka, J.
Bator, M.
Kalicińska, E.
Wróbel, T.
Usnarska-Zubkiewicz, L.
Rybka, J.
Dereń-Wagemann, I.
Szyca-Śmieszniak, M.
Dybko, J.
Hus, I.
Puła, B.
Cichocka, E.
Rymko, M.
Zduńczyk, D.
Ziarkiewicz, M.
Basak, G.
Bullinger, L.
Giannopoulos, K.
author_facet Zaleska, J.
Kwaśnik, P.
Paziewska, M.
Purkot, J.
Szabelak, A.
Jurek, M.
Masny, N.
Dziatkiewicz, I.
Własiuk, P.
Skórka, K.
Stasiak, G.
Pronobis-Szczylik, B.
Piebiak, A.
Szymczyk, A.
Jarosz-Chudzik, K.
Bołkun, L.
Kozłowska, K.
Piszcz, J.
Subocz, E.
Hałka, J.
Bator, M.
Kalicińska, E.
Wróbel, T.
Usnarska-Zubkiewicz, L.
Rybka, J.
Dereń-Wagemann, I.
Szyca-Śmieszniak, M.
Dybko, J.
Hus, I.
Puła, B.
Cichocka, E.
Rymko, M.
Zduńczyk, D.
Ziarkiewicz, M.
Basak, G.
Bullinger, L.
Giannopoulos, K.
author_sort Zaleska, J.
collection PubMed
description
format Online
Article
Text
id pubmed-9429419
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94294192022-08-31 P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS Zaleska, J. Kwaśnik, P. Paziewska, M. Purkot, J. Szabelak, A. Jurek, M. Masny, N. Dziatkiewicz, I. Własiuk, P. Skórka, K. Stasiak, G. Pronobis-Szczylik, B. Piebiak, A. Szymczyk, A. Jarosz-Chudzik, K. Bołkun, L. Kozłowska, K. Piszcz, J. Subocz, E. Hałka, J. Bator, M. Kalicińska, E. Wróbel, T. Usnarska-Zubkiewicz, L. Rybka, J. Dereń-Wagemann, I. Szyca-Śmieszniak, M. Dybko, J. Hus, I. Puła, B. Cichocka, E. Rymko, M. Zduńczyk, D. Ziarkiewicz, M. Basak, G. Bullinger, L. Giannopoulos, K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429419/ http://dx.doi.org/10.1097/01.HS9.0000848612.55618.07 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Zaleska, J.
Kwaśnik, P.
Paziewska, M.
Purkot, J.
Szabelak, A.
Jurek, M.
Masny, N.
Dziatkiewicz, I.
Własiuk, P.
Skórka, K.
Stasiak, G.
Pronobis-Szczylik, B.
Piebiak, A.
Szymczyk, A.
Jarosz-Chudzik, K.
Bołkun, L.
Kozłowska, K.
Piszcz, J.
Subocz, E.
Hałka, J.
Bator, M.
Kalicińska, E.
Wróbel, T.
Usnarska-Zubkiewicz, L.
Rybka, J.
Dereń-Wagemann, I.
Szyca-Śmieszniak, M.
Dybko, J.
Hus, I.
Puła, B.
Cichocka, E.
Rymko, M.
Zduńczyk, D.
Ziarkiewicz, M.
Basak, G.
Bullinger, L.
Giannopoulos, K.
P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
title P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
title_full P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
title_fullStr P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
title_full_unstemmed P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
title_short P1439: IMMUNE RESPONSE TO ANTI-SARS-COV-2 MRNA VACCINES IN MULTIPLE MYELOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS
title_sort p1439: immune response to anti-sars-cov-2 mrna vaccines in multiple myeloma and chronic lymphocytic leukemia patients
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429419/
http://dx.doi.org/10.1097/01.HS9.0000848612.55618.07
work_keys_str_mv AT zaleskaj p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT kwasnikp p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT paziewskam p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT purkotj p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT szabelaka p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT jurekm p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT masnyn p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT dziatkiewiczi p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT własiukp p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT skorkak p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT stasiakg p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT pronobisszczylikb p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT piebiaka p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT szymczyka p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT jaroszchudzikk p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT bołkunl p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT kozłowskak p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT piszczj p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT subocze p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT hałkaj p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT batorm p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT kalicinskae p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT wrobelt p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT usnarskazubkiewiczl p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT rybkaj p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT derenwagemanni p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT szycasmieszniakm p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT dybkoj p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT husi p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT pułab p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT cichockae p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT rymkom p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT zdunczykd p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT ziarkiewiczm p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT basakg p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT bullingerl p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients
AT giannopoulosk p1439immuneresponsetoantisarscov2mrnavaccinesinmultiplemyelomaandchroniclymphocyticleukemiapatients